SCHEMBL7434651

SCHEMBL7434651

CCCN(CCC)C1CCc2c(ccc3[nH]ccc23)C1

nearest known ligand 0.83

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 15/20 0.83
HTR1B P28222 11/20 0.83
DRD2 P14416 2/20 0.59
DRD1 P21728 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8315482 0.91 HTR1D (1.00) HTR1DHTR1B
SCHEMBL7436234 0.90 HTR1D (0.86) HTR1DHTR1BDRD2DRD1
SCHEMBL7437193 0.90 HTR1D (0.78) HTR1DHTR1BDRD2
SCHEMBL7447504 0.88 HTR1D (0.84) HTR1DHTR1BDRD2
SCHEMBL7442744 0.88 HTR1D (0.81) HTR1DHTR1B
SCHEMBL7439303 0.86 HTR1D (0.87) HTR1DHTR1BDRD2DRD1
SCHEMBL8316283 0.83 HTR1D (1.00) HTR1DHTR1BDRD2
SCHEMBL7437054 0.82 HTR1D (0.60) HTR1DHTR1BDRD2DRD1
SCHEMBL8315256 0.81 HTR1D (1.00) HTR1DHTR1B
SCHEMBL8316440 0.81 HTR1D (1.00) HTR1DHTR1BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0055043-B1 6,7,8,9-TETRAHYDRO-3H-BENZ(E)INDOLAMINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND INTERMEDIATES USED THEREIN, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE INDOLAMINE DERIVATIVES AYERST, MCKENNA AND HARRISON INC. (CA) 1985-01-23 EP claimed
US-4454150-A 6,7,8,9-Tetrahydro-3H-benz(e)indol-7-amines and a method of dopamine receptor stimulation therewith AYERST, MCKENNA & HARRISON INC. (US) 1984-06-12 US claimed
EP-0055043-A2 6,7,8,9-Tetrahydro-3H-benz(e)indolamine derivatives, processes for their preparation and intermediates used therein, and pharmaceutical compositions containing the indolamine derivatives AYERST, MCKENNA AND HARRISON INC. (CA) 1982-06-30 EP claimed
US-6291494-B1 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use ASTRAZENECA AB (SE) 2001-09-18 US disclosed
EP-0690843-B1 Formyl- or cyano- substituted indole derivatives having dopaminergic activity UPJOHN CO (US) 2000-08-30 EP disclosed
US-5639778-A TREATING CENTRAL NERVOUS SYSTEM DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1997-06-17 US disclosed
EP-0690843-A1 INDOLETETRALINS HAVING DOPAMINERGIC ACTIVITY PHARMACIA & UPJOHN COMPANY (US) 1996-01-10 EP disclosed
WO-1994021608-A1 INDOLETETRALINS HAVING DOPAMINERGIC ACTIVITY THE UPJOHN COMPANY (US) 1994-09-29 WO disclosed
EP-0055043-B1 6,7,8,9-TETRAHYDRO-3H-BENZ(E)INDOLAMINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND INTERMEDIATES USED THEREIN, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE INDOLAMINE DERIVATIVES AYERST, MCKENNA AND HARRISON INC. (CA) 1985-01-23 EP disclosed
US-4454150-A 6,7,8,9-Tetrahydro-3H-benz(e)indol-7-amines and a method of dopamine receptor stimulation therewith AYERST, MCKENNA & HARRISON INC. (US) 1984-06-12 US disclosed
EP-0055043-A2 6,7,8,9-Tetrahydro-3H-benz(e)indolamine derivatives, processes for their preparation and intermediates used therein, and pharmaceutical compositions containing the indolamine derivatives AYERST, MCKENNA AND HARRISON INC. (CA) 1982-06-30 EP disclosed